Geometry Dash APK Hill Climb Racing APK
34.9 F
New York
Saturday, December 10, 2022

Innovus Pharmaceuticals, Inc. (OTMKTS:INNV) Launches Higher on Major New Pilot Program

Must read

Is Tilray Inc (NASDAQ:TLRY) Stock a Good Buy After The Recent Fall?

The cannabis sector may have had a hard time not too long ago but over the course of the past months, the...

Sysorex Inc (OTCMKTS:SYSX) Stock Still Riding Big News

Investors are always drawn to stocks that make a big jump out of nowhere. So it's no surprise that Sysorex Inc (OTCMKTS:SYSX)...

88 Energy Limited Ltd (EEENF) Update: Continues Climbing on Significant Volume

Investors who might be looking for stocks that have made considerable gains in recent weeks could consider having a closer look at...

Victory Resources Corporation (OTCMKTS:VRCFF) Stock Rockets After Announcing A New Acquisition

Nowadays, lithium is in huge demand across several industries and hence, it the rally in the Victory Resources Corporation (OTCMKTS:VRCFF) stock the...

One of the more remarkable reasons we follow small and micro-cap names is because they can explode higher by a massive magnitude with little or no warning, such as we saw out of Innovus Pharmaceuticals, Inc. (OTMKTS:INNV) on Wednesday. Behind the move, the company just announced that it has entered into a pilot program with the nationwide pharmaceutical chain CVS Pharmacy, Inc., which is a subsidiary of CVS Health Corp (NYSE: CVS), to sell the Company’s product Androferti, to increase sperm quality.

According to the release, “If successful, the CVS pilot program could lead to the national pharmacy stocking and selling Androferti on a scalable level nationwide and could expand to add additional Innovus Pharma products. Androferti is a patented dietary supplement shown in multiple published clinical trials to statistically increase seminal quality (concentration, motility, morphology and vitality) and enhance spermatozoa quality (decreases of vacuoles in the sperm nucleus, decreases DNA fragmentation, decreases the dynamics of sperm DNA fragmentation, and improvement on the inventory of mobile sperm.”

Innovus Pharmaceuticals, Inc. (OTCMKTS: INNV), a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States.

The company’s products include Zestra, a non-medicated patented consumer care product to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine-based topical gel for treating premature ejaculation; Sensum+, a non-medicated consumer care cream that enhances penile sensitivity; Zestra Glide, a high viscosity and low osmolality water-based lubricant; Vesele, a proprietary oral dietary supplement to enhance nitric oxide beneficial clinical effects on sexual functions and brain health; and Androferti to support overall male reproductive health and sperm quality.

INNV also has a number of product lines gestating in the pipeline, including FlutiCare, an over the counter drug for Rhinitis; Urocis for urinary tract infection; and AndroVit, a proprietary supplement to support overall prostate and male sexual health.

In response to the company’s recent surge in topline growth, INNV investors have been rewarded by upgrades to future outlooks by both SeeThruEquity and Zack’s research. Price targets now reach as high as $1/share and above.

Find out when INNV stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

As noted in the company’s latest release, the company believes that Androferti is the only product clinically proven in multiple published clinical trials to increase the Sperm Quality and enhance Spermatozoa Quality as compared to other products where the claims are based primarily on an ingredient used in the products.

The chart shows 66% piled on for shareholders of the listing during the trailing week. Moreover, the stock has benefitted from a jump in recent trading volume to the tune of just under 240% above its longer-run average levels.

“We are very pleased to have been chosen by CVS to be part of their newly established in-store men’s health clinic,” said Dr. Bassam Damaj, the President and Chief Executive Officer of Innovus Pharma. “In addition, we are in discussion to potentially add more product under this program.”

At this time, carrying a capital value in the market of $23M, INNV has a significant war chest ($4.9M) of cash on the books, which is balanced by about $2.3M in total current liabilities. One should also note that debt has been growing over recent quarters. INNV is pulling in trailing 12-month revenues of $11.2M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 108.7%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $INNV stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $INNV, either long or short, and we have not been compensated for this article.

Latest article

Alibaba Group Holding Limited (OTCMKTS:BABAF) Big Volume with Possible 60% Upside

Alibaba Group Holding Limited (OTCMKTS:  BABAF) is an over the counter stock traded on the OTC Pink markets in the Consumer Discretionary...

Trans Global Group Inc (OTCMKTS:TGGI) Stock In Focus After Operational Updates

The Trans Global Group Inc (OTCMKTS:TGGI) stock may not have been in the news today yet but it...

Why Hycroft Mining (NASDAQ:HYMC) Stock Shot Up 700%

If you are on the hunt for stocks that may have made major gains over the course of the past week, then...

Secure Paymentz releases banking software demo on Github

This is a paid announcement from one of our advertising partners. How to Leverage Your Trading Position by Secure...

Advanced Asset Management Announces New Website Launch

This is a paid announcement from one of our advertising partners. Financial Planner in Grandville, Michigan
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service